200 related articles for article (PubMed ID: 21046073)
21. Clostridium difficile toxin A-induced apoptosis is p53-independent but depends on glucosylation of Rho GTPases.
Nottrott S; Schoentaube J; Genth H; Just I; Gerhard R
Apoptosis; 2007 Aug; 12(8):1443-53. PubMed ID: 17437185
[TBL] [Abstract][Full Text] [Related]
22. Protection from Clostridium difficile toxin B-catalysed Rac1/Cdc42 glucosylation by tauroursodeoxycholic acid-induced Rac1/Cdc42 phosphorylation.
Brandes V; Schelle I; Brinkmann S; Schulz F; Schwarz J; Gerhard R; Genth H
Biol Chem; 2012 Jan; 393(1-2):77-84. PubMed ID: 22628301
[TBL] [Abstract][Full Text] [Related]
23. Early cell death induced by Clostridium difficile TcdB: Uptake and Rac1-glucosylation kinetics are decisive for cell fate.
Beer LA; Tatge H; Reich N; Tenspolde M; Olling A; Goy S; Rottner K; Alekov AK; Gerhard R
Cell Microbiol; 2018 Oct; 20(10):e12865. PubMed ID: 29904993
[TBL] [Abstract][Full Text] [Related]
24. Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470.
Huelsenbeck J; Dreger S; Gerhard R; Barth H; Just I; Genth H
Infect Immun; 2007 Feb; 75(2):801-9. PubMed ID: 17145947
[TBL] [Abstract][Full Text] [Related]
25. A segment of 97 amino acids within the translocation domain of Clostridium difficile toxin B is essential for toxicity.
Zhang Y; Shi L; Li S; Yang Z; Standley C; Yang Z; ZhuGe R; Savidge T; Wang X; Feng H
PLoS One; 2013; 8(3):e58634. PubMed ID: 23484044
[TBL] [Abstract][Full Text] [Related]
26. Cellular uptake of Clostridium difficile TcdA and truncated TcdA lacking the receptor binding domain.
Gerhard R; Frenzel E; Goy S; Olling A
J Med Microbiol; 2013 Sep; 62(Pt 9):1414-1422. PubMed ID: 23558138
[TBL] [Abstract][Full Text] [Related]
27. Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A.
Huang JH; Shen ZQ; Lien SP; Hsiao KN; Leng CH; Chen CC; Siu LK; Chong PC
PLoS One; 2015; 10(8):e0135045. PubMed ID: 26271033
[TBL] [Abstract][Full Text] [Related]
28. Clostridium difficile Toxin Biology.
Aktories K; Schwan C; Jank T
Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
[TBL] [Abstract][Full Text] [Related]
29. Antibody-enhanced, Fc gamma receptor-mediated endocytosis of Clostridium difficile toxin A.
He X; Sun X; Wang J; Wang X; Zhang Q; Tzipori S; Feng H
Infect Immun; 2009 Jun; 77(6):2294-303. PubMed ID: 19307220
[TBL] [Abstract][Full Text] [Related]
30. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
Genth H; Dreger SC; Huelsenbeck J; Just I
Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
[TBL] [Abstract][Full Text] [Related]
31. Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.
Zhang Y; Hamza T; Gao S; Feng H
Biochem Biophys Res Commun; 2015 Apr; 459(2):259-263. PubMed ID: 25725153
[TBL] [Abstract][Full Text] [Related]
32. A neutralizing antibody that blocks delivery of the enzymatic cargo of
Kroh HK; Chandrasekaran R; Zhang Z; Rosenthal K; Woods R; Jin X; Nyborg AC; Rainey GJ; Warrener P; Melnyk RA; Spiller BW; Lacy DB
J Biol Chem; 2018 Jan; 293(3):941-952. PubMed ID: 29180448
[No Abstract] [Full Text] [Related]
33. Structure-function analysis of inositol hexakisphosphate-induced autoprocessing in Clostridium difficile toxin A.
Pruitt RN; Chagot B; Cover M; Chazin WJ; Spiller B; Lacy DB
J Biol Chem; 2009 Aug; 284(33):21934-21940. PubMed ID: 19553670
[TBL] [Abstract][Full Text] [Related]
34. Binding of Clostridium difficile toxins to human milk oligosaccharides.
El-Hawiet A; Kitova EN; Kitov PI; Eugenio L; Ng KK; Mulvey GL; Dingle TC; Szpacenko A; Armstrong GD; Klassen JS
Glycobiology; 2011 Sep; 21(9):1217-27. PubMed ID: 21610194
[TBL] [Abstract][Full Text] [Related]
35. Rho protein inactivation induced apoptosis of cultured human endothelial cells.
Hippenstiel S; Schmeck B; N'Guessan PD; Seybold J; Krüll M; Preissner K; Eichel-Streiber CV; Suttorp N
Am J Physiol Lung Cell Mol Physiol; 2002 Oct; 283(4):L830-8. PubMed ID: 12225960
[TBL] [Abstract][Full Text] [Related]
36. Identification of an Essential Region for Translocation of Clostridium difficile Toxin B.
Chen S; Wang H; Gu H; Sun C; Li S; Feng H; Wang J
Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27537911
[TBL] [Abstract][Full Text] [Related]
37. Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin.
Hofmann F; Busch C; Prepens U; Just I; Aktories K
J Biol Chem; 1997 Apr; 272(17):11074-8. PubMed ID: 9111001
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Clostridium difficile TcdA and TcdB toxins with transition state analogues.
Paparella AS; Aboulache BL; Harijan RK; Potts KS; Tyler PC; Schramm VL
Nat Commun; 2021 Nov; 12(1):6285. PubMed ID: 34725358
[TBL] [Abstract][Full Text] [Related]
39. Processing of Clostridium difficile toxins.
Giesemann T; Egerer M; Jank T; Aktories K
J Med Microbiol; 2008 Jun; 57(Pt 6):690-696. PubMed ID: 18480324
[TBL] [Abstract][Full Text] [Related]
40. The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+ and UDP provides insights into glucosyltransferase activity and product release.
D'Urzo N; Malito E; Biancucci M; Bottomley MJ; Maione D; Scarselli M; Martinelli M
FEBS J; 2012 Sep; 279(17):3085-97. PubMed ID: 22747490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
